MILAN — Antidepressants escitalopram and duloxetine have been shown to improve verbal memory in moderate to severe depression, a clinical effect linked to changes in serotonin 4 (5-HT4) receptor ...
Researchers have found that SSRI (Selective Serotonin Reuptake Inhibitors) antidepressants have the potential to improve certain cognitive functions, such as verbal memory. They measured brain ...
A study published in Biological Psychiatry investigated the role of the 5-HT4 receptor (5-HT4R) in patients with major depressive disorder (MDD) and how changes in this receptor may relate to the ...
(RTTNews) - First Wave BioPharma, Inc., (FWBI) announced an agreement with Sanofi (SNY) to license Capeserod, a selective 5-HT4 receptor partial agonist, which First Wave will repurpose and develop ...
Processa Pharmaceuticals, Inc. has announced a licensing agreement with Intact Therapeutics for PCS12852, a novel 5-HT4 receptor agonist aimed at treating gastroparesis and gastrointestinal motility ...
Several 5-HT4 receptor (5-HT4R) agonists are approved for treating chronic idiopathic constipation (CIC) by stimulating gastrointestinal (GI) motility. Traditional 5-HT4R agonists act systemically, ...
First Wave BioPharma Inc (NASDAQ:FWBI) announced an agreement with Sanofi SA (NASDAQ:SNY) to license Capeserod, a selective 5-HT4 receptor partial agonist, which First Wave will repurpose and develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results